首页> 外文期刊>Orthopedics >Economic Analysis of Anatomic Plating Versus Tubular Plating for the Treatment of Fibula Fractures
【24h】

Economic Analysis of Anatomic Plating Versus Tubular Plating for the Treatment of Fibula Fractures

机译:解剖学镀层与管状电镀治疗腓骨骨折的经济分析

获取原文
获取原文并翻译 | 示例
       

摘要

Ankle fractures are among the most common injuries requiring operative management. Implant choices include one-third tubular plates and anatomically precontoured plates. Although cadaveric studies have not revealed biomechanical differences between various plate constructs, there are substantial cost differences. This study sought to characterize the economic implications of implant choice. A retrospective review was undertaken of 201 consecutive patients with operatively treated OTA type 44B and 44C ankles. A Nationwide Inpatient Sample query was performed to estimate the incidence of ankle fractures requiring fibular plating, and a Monte Carlo simulation was conducted with the estimated at-risk US population for associated plate-specific costs. The authors estimated an annual incidence of operatively treated ankle fractures in the United States of 59,029. The average cost was $90.86 (95% confidence interval, $90.84-$90.87) for a one-third tubular plate vs $746.97 (95% confidence interval, $746.55-$747.39) for an anatomic plate. Across the United States, use of only one-third tubular plating over anatomic plating would result in statistically significant savings of $38,729,517 (95% confidence interval, $38,704,773-$38,754,261; P.0001). General use of one-third tubular plating instead of anatomic plating whenever possible for fibula fractures could result in cost savings of up to nearly $40 million annually in the United States. Unless clinically justifiable on a per-case basis, or until the advent of studies showing substantial clinical benefit, there currently is no reason for the increased expense from widespread use of anatomic plating for fractures amenable to one-third tubular plating.
机译:脚踝骨折是需要操作管理的最常见的伤害之一。植入物选项包括三个管状板和解剖学预型板。虽然尸体研究没有揭示各种板结构之间的生物力学差异,但存在具有大量成本差异。该研究寻求表征植入物选择的经济影响。回顾性审查是对201型44B和44C脚踝可操作处理的可操作性患者的201连续患者。进行了全国性住院样品查询以估计需要腓孔的踝骨骨折的发生率,并且蒙特卡罗模拟与估计的美国群体进行了相关的纸币的特定成本。作者估计,美国可操作地治疗的踝关节骨折在美国59,029中。平均成本为单三分管板的平均成本为90.86美元(95%的置信区间,90.84美元90.87美元)与解剖板的746.97美元(95%置信区间,746.55美元至747.39美元)。在美国,在解剖电镀中只使用三分之一的管状电镀将导致统计上显着的节省38,729,517美元(95%置信区间,38,704,773- $ 38,754,261; p& .0001)。一般使用三分之一的管状电镀而不是解剖电镀,只要腓骨骨折可能导致在美国每年的成本节省高达4000万美元。除非按案例的基础合理,否则直到显示大量临床福利的研究出现,否则目前没有理由从广泛使用解剖学镀层的骨折,仍然没有得到增加的折衷折痕。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号